Filing Details
- Accession Number:
- 0001209191-15-070098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-10 16:06:27
- Reporting Period:
- 2015-09-08
- Filing Date:
- 2015-09-10
- Accepted Time:
- 2015-09-10 16:06:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578408 | Nick Leschly | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-09-08 | 125,000 | $5.50 | 371,521 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-09-08 | 2,100 | $131.01 | 369,421 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-08 | 8,300 | $131.70 | 361,121 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-08 | 5,216 | $132.64 | 355,905 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-08 | 12,241 | $133.96 | 343,664 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-08 | 37,375 | $134.86 | 306,289 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-08 | 22,610 | $135.75 | 283,679 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-08 | 25,758 | $136.80 | 257,921 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-08 | 10,200 | $137.76 | 247,721 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-09-08 | 1,200 | $138.53 | 246,521 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-09-08 | 125,000 | $0.00 | 125,000 | $5.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
265,269 | 2023-01-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 7,504 | Indirect | Nick Leschly 2001 Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015.
- The range of prices for the transaction reported on this line was $130.14 to $131.14. The average weighted price was $131.0064. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $131.16 to $132.12. The average weighted price was $131.7037. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $132.31 to $133.29. The average weighted price was $132.6365. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $133.32 to $134.32. The average weighted price was $133.9559. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $134.33 to $135.33. The average weighted price was $134.8592. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $135.34 to $136.30. The average weighted price was $135.7520. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $136.35 to $137.34. The average weighted price was $136.8012. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $137.375 to $138.185. The average weighted price was $137.7611. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.